FoundationN.K.NKF-K/DOQI Clinical practice guidelines for vascular access: Update 2000.Am J Kidney Dis2001; 37(Suppl 1): S137–81.
3.
PisoniR.L., YoungE.W., DykstraD.M.. Vascular access use in Europe and United States Results from the DOPPS.Kidney Int2002; 61: 305–16.
4.
PastanS., SoucieJ.M., McClellanW.M.Vascular access and increased risk of death among hemodialysis patients.Kidney Int2002; 62: 620–6.
5.
CharmaineE.Lok, Debra Appleton, Cynthia Bhola, Brian Khoo, Robert M. A. Richardson. Trisodium citrate 4% - an alternative to heparin capping of haemodialysis catheters.Nephrol Dial Transplant2007; 22: 477–83.
6.
GrudzinskiL., QuinanP., KwokS., PierratosA.Sodium citrate 4% locking solution for central venous dialysis catheters - an effective, more cost-efficient alternative to heparin.Nephrol Dial Transplant2007; 22: 471–6.
7.
MichaudD., KomantT., PfefferleP.Four percent trisodiumcitrate as an alternative anticoagulant for maintaining patency of central venous hemodialysis catheters: case report and discussion.Am J Crit Care2001; 10: 351–4.
8.
HendrickxL., KuypersD., EvenepoelP., MaesB., MessiaenT., VanrenterghemY.A comparative prospective study on the use of low concentrate citrate lock versus heparin lock in permanent dialysis catheters.Int J Artif Organs2001; 24: 208–11.
9.
WarkentinT.E., LevineM.N., HirshJ.. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or Unfractionated Heparin.N Engl J Med1995; 332: 1330–6.
10.
KaraaslanH., PeyronnetP., BeneventD., LagardeC., RinceM., Leroux-RobertC.Risk of heparin lock-related bleeding when using indwelling venous catheter in haemodialysis.Nephrol Dial Transplant2001; 16: 2072–4.
11.
PolascheggH.D., SodemannK.Risks related to catheter locking solutions containing concentrated citrate.Nephrol Dial Transplant2003; 18: 2688–90.
